Q1 2023 Holdings
Filed 2023-05-15 | 62 holdings | $1.4B | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2023-11-08) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr S&P 500 ETF TR | PUT | 78462F953 | $22.0M | 4,100 | 1.9% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $24.8M | 689,676 | 1.7% |
| Danaher Corporation(DHR) | COM | 235851102 | $37.5M | 148,685 | 2.6% |
| Catalent Inc(CTLTEUR) | COM | 148806102 | $37.7M | 573,609 | 2.6% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $37.7M | 4,520,724 | 2.6% |
| Illumina Inc(ILMN) | COM | 452327109 | $39.7M | 170,537 | 2.8% |
| Biogen Inc(BIIB) | COM | 09062X103 | $42.8M | 153,774 | 3.0% |
| Community Health SYS Inc New(CYH) | COM | 203668108 | $44.5M | 9,082,305 | 3.1% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $46.7M | 2,209,057 | 3.3% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $49.7M | 222,107 | 3.5% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $54.8M | 6,194,572 | 3.8% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $89.4M | 819,124 | 6.2% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $133.9M | 3,731,499 | 9.3% |
| Invesco QQQ TR(QQQ)PutA | UNIT SER 1 | 46090E103 | $144.4M | 450,000 | 10.1% |
| Natera Inc(NTRA) | COM | 632307104 | $156.6M | 2,819,770 | 10.9% |
| Spdr S&P 500 ETF TR TR(SPY)PutA | TR UNIT | 78462F103 | $167.8M | 410,000 | 11.7% |